This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
PDX1 / Pancreas/duodenum homeobox protein 1 · IHC design guide
Design Immunohistochemistry for PDX1
PDX1 IHC shows nuclear staining in pancreatic islet cells, intercalated ducts and intestinal enterocytes (HPA tissue IHC). For paraffin sections, start with the catalog antibody at 1:50 (datasheet M00491) and assess nuclear signal by cell type.
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
PDX1 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Nuclear staining in pancreas and intestine (HPA tissue IHC) | |
| Staining pattern | Nuclear islet cells, intercalated ducts and enterocytes (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet M00491) | |
| Positive control | Duodenum+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation consistent across sections (standard IHC practice; not target-specific). Selected-image fixative and duration unreported (datasheet M00491); verify before use. | |
| Caveat | Enterocytes and intercalated ducts also stain (HPA tissue IHC) | |
| Regulation | Expression regulation unreported (UniProt) | |
| Isoform / epitope | No annotated isoforms or cleavage; one 1–283 chain (UniProt) |
Section 1
Recommended PDX1 IHC & IF Protocols
The catalog antibody has a datasheet IHC-P protocol (datasheet M00491). These four published PDX1 IHC protocols provide tissue and detection examples (PMC3123421; PMC7667445; PMC5608307; PMC9710085).
| Sample | Paraffin-embedded human stomach cancer tissue; fixative not specified (datasheet M00491) |
| Fixation | Image fixative and duration unreported (datasheet M00491); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet M00491); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet M00491) |
| Primary antibody | Rabbit monoclonal (clone AEC-16) anti-PDX1, 1:50 (datasheet M00491) |
| Primary incubation | Overnight at 4 °C (datasheet M00491) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet M00491) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | PDX1-positive staining in enterocytes of duodenum (HPA tissue IHC: High). HPA tissue profile: Selective nuclear expression in islets of Langerhans and intercalated ducts in pancreas, as well as in duodenum and small intestine. No signal in the no-primary control. |
💡Decision noteStart with EDTA pH 8.0 heat retrieval for the catalog antibody (datasheet M00491). Match the cited retrieval conditions when using a published antibody protocol (PMC3123421; PMC9710085).
Section 2
What Is the Expected PDX1 Staining Pattern?
PDX1 should appear mainly in nuclei of pancreatic islet endocrine cells, pancreatic intercalated ducts, and intestinal epithelium; duodenal enterocytes and pancreatic endocrine cells show high staining (HPA tissue IHC: Enhanced reliability). UniProt also annotates cytosol, but PDX1 has no transmembrane segment (UniProt P52945: subcellular location and topology).
| Distinct nuclear chromogen in pancreatic islet endocrine cells, with staining in intercalated ducts. | This matches the selective pancreatic pattern (HPA tissue IHC: Enhanced). Judge positive cells by nuclear staining; the distribution across the section matters more than isolated dark deposits (general IHC practice). |
| Predominantly cytoplasmic staining with little or no nuclear signal. | Treat this as a possible staining artefact in this IHC setting because the reported tissue pattern is nuclear (HPA tissue IHC). Cytosolic location is also annotated, so cytoplasmic signal alone cannot be declared biologically impossible (UniProt P52945: subcellular location). |
| Strong staining in cells expected to be negative, such as adrenal glandular or bronchial respiratory epithelial cells. | These cell types were reported as not detected (HPA tissue IHC). Consider antibody cross-reactivity or endogenous detection activity, then compare with appropriate control sections (general IHC practice). |
| Diffuse chromogen covers nuclei, cytoplasm, and tissue spaces without a selective cellular pattern. | The result cannot establish PDX1 positivity. It departs from the selective nuclear pattern (HPA tissue IHC); excess detection background or incomplete blocking are general IHC possibilities. |
| No nuclear staining in a well-preserved pancreas section containing identifiable islets. | An islet provides an expected positive population (HPA tissue IHC: pancreatic endocrine cells, High). Check assay performance before calling the sample negative; absence of signal alone does not identify which workflow step failed (general IHC practice). |
💡Expected PDX1 appearanceCall a result positive when nuclei stain clearly in pancreatic islet endocrine cells or duodenal enterocytes, both reported High (HPA tissue IHC); broad staining of unrelated cells or tissue spaces is suspect (general IHC practice).
| Which tissue and cells should anchor the IHC readout? | Pancreatic endocrine cells and duodenal enterocytes are High; small-intestinal enterocytes are Medium (HPA tissue IHC). Identify the cell population before comparing intensity, since a whole-section average can obscure selective staining (general IHC practice). |
| How strong is the antibody-pattern evidence? | The tissue profile has Enhanced reliability and agreement with RNA expression (HPA tissue IHC). Two listed antibodies, HPA059146 and CAB025873, each have Enhanced IHC validation (HPA antibodies); this supports the reported pattern without proving that every staining run will succeed. |
| Does cellular location alter the interpretation? | PDX1 is a transcription regulator with nuclear and cytosolic annotations and no transmembrane segment (UniProt P52945: function, location, topology). Nuclear enrichment is the practical IHC expectation because the observed tissue profile is selectively nuclear (HPA tissue IHC). |
| Does IF/ICC have the same expected compartment? | Yes: the supported ICC-IF main location is nucleoplasm (HPA subcellular: supported). This cross-check concerns localisation only; it does not supply an IF/ICC protocol or establish that IHC and IF signals have matching intensity. |
| Situation | Likely cause | Next action |
|---|---|---|
| Pancreatic islets are present, but their nuclei show no signal. | The positive population is identifiable yet unstained (HPA tissue IHC: pancreatic endocrine cells, High); the cause cannot be assigned from the slide alone. | Run a known-positive control alongside the section and check the IHC-validated antibody, retrieval, primary incubation, and detection steps as general IHC workflow checks. |
| Duodenal enterocytes stain weakly or unevenly. | High staining is reported for this population (HPA tissue IHC), but the payload does not establish a PDX1-specific fixation or retrieval effect. | Compare with a positive control processed in the same run; review section quality, retrieval conditions, and reagent handling as general IHC checks before changing the biological interpretation. |
| Chromogen appears broadly in expected negative cell populations. | For example, adrenal glandular cells are reported as not detected (HPA tissue IHC); cross-reactivity or endogenous detection activity may contribute (general IHC practice). | Compare the expected-positive pattern with negative tissue and a no-primary control; review endogenous-activity blocking where relevant to the detection system (general IHC practice). |
| Cytoplasmic staining dominates while nuclei remain pale. | That distribution conflicts with the selective nuclear tissue profile (HPA tissue IHC), although UniProt also annotates cytosol (UniProt P52945: location). | Check counterstain and cellular boundaries, compare a known-positive section, and assess background controls before treating the cytoplasmic signal as specific (general IHC practice). |
| Background obscures the boundary between stained and unstained nuclei. | Diffuse deposit prevents assessment of the selective nuclear pattern (HPA tissue IHC); several staining or detection steps can contribute (general IHC practice). | Review blocking, washes, primary-antibody concentration, and chromogen development against a no-primary control (general IHC practice). |
| A small-intestine section looks less intense than a duodenum control. | Enterocytes are reported Medium in small intestine and High in duodenum (HPA tissue IHC); this difference alone does not show assay failure. | Score nuclear positivity within each named cell population and compare like tissues across runs; use the pancreas or duodenum positive control to assess assay performance (HPA tissue IHC; general IHC practice). |
Experiment evidence
IHC & IF images showing PDX1 staining
M00491 · IHCIHC analysis of PDX1/Ipf1 using anti-PDX1/Ipf1 antibody (M00491). PDX1/Ipf1 was detected in a paraffin-embedded section of human stomach can
M00491 · IHCIHC analysis of PDX1/Ipf1 using anti-PDX1/Ipf1 antibody (M00491). PDX1/Ipf1 was detected in a paraffin-embedded section of human stomach can
A00491-4 · IFIF analysis of PDX1 using anti-PDX1 antibody (A00491-4) and anti-Beta Tubulin antibody (M01857-3). PDX1 was detected in immunocytochemical s
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000139515-PDX1/tissue/cerebral+cortex#imid_6460648
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000139515-PDX1/tissue/colon#imid_6460574
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000139515-PDX1/tissue/liver#imid_6460567
HPA · PancreasHuman Protein Atlas IHC, Pancreas. Source: https://www.proteinatlas.org/ENSG00000139515-PDX1/tissue/pancreas#imid_6460510
HPA · ICC-IF HeLaHuman Protein Atlas immunofluorescence, HeLa, antibody HPA059146; green = PDX1, blue = nucleus, red = microtubules.
HPA · ICC-IF HeLaHuman Protein Atlas immunofluorescence, HeLa, antibody HPA059146; green = PDX1, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for PDX1 IHC & IF
🧪Run pancreas first: pancreatic endocrine cells should stain strongly (HPA: High in pancreatic endocrine cells). Use adipose tissue as the negative tissue (HPA: Not detected in adipocytes); on the pancreas slide, compare endocrine nuclei with surrounding non-endocrine cells, allowing for low acinar expression (UniProt P52945 tissue specificity).
Positive control tissue: Duodenum (Enterocytes, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show PDX1 in HeLa, with annotated localisation: Nucleoplasm (supported) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control and a rabbit IgG isotype control matched to the primary antibody where its isotype is known (selected-SKU caption: rabbit primary and goat anti-rabbit secondary); use PDX1 knockout material as a biological negative if available (standard IHC practice). Quench endogenous peroxidase for HRP/DAB detection in pancreas sections, and check endogenous biotin if using avidin–biotin detection (standard IHC practice; selected-SKU caption: HRP/DAB detection).
⚠️Feasibility: A target-specific fixation window and fixation effect are unreported, and the exact M00491 tissue-IHC caption does not state a fixative (selected-SKU caption: fixative not stated). Heat-mediated EDTA retrieval at pH 8.0 is documented for a paraffin section, but whether staining depends on retrieval is unreported; the supplied evidence does not establish that frozen sections or IF are easier (selected-SKU caption: EDTA retrieval; HPA: nucleoplasmic ICC-IF localization in HeLa). In pancreas, assess nuclear endocrine staining against adjacent acinar staining, which may be low (UniProt P52945: nuclear localization and low acinar expression).
HPA tissue IHC evidence for PDX1
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Duodenum | Enterocytes | High | Protein (IHC) | HPA → |
| Pancreas | Pancreatic endocrine cells | High | Protein (IHC) | HPA → |
| Appendix | Enterocytes | Medium | Protein (IHC) | HPA → |
| Colon | Enterocytes | Medium | Protein (IHC) | HPA → |
| Rectum | Enterocytes | Medium | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | Respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced PDX1 IHC Tips
Troubleshoot PDX1 chromogenic IHC by checking nuclear staining, tissue controls, and processing conditions before interpreting signal intensity (HPA: selective nuclear expression).
Which retrieval condition should I start with for PDX1 staining in paraffin sections?
Start with heat-mediated EDTA retrieval at pH 8.0 for paraffin sections (datasheet M00491). The selected image used this condition with a 1:50 primary dilution overnight at 4°C (caption M00491). If nuclear signal is weak, compare shorter and longer heating on adjacent sections while keeping antibody dilution and DAB development constant (standard IHC practice). Excess heating can impair tissue morphology, so choose the condition that preserves architecture and gives crisp nuclei in pancreatic islets or duodenal epithelium (standard IHC practice; HPA: selective nuclear expression). Record retrieval time and temperature alongside the fraction of nuclei stained for reproducible comparisons (standard IHC practice).
How should I investigate weak PDX1 staining when fixation history varies between blocks?
Target-specific fixation sensitivity is unknown: the selected paraffin-section caption does not report its fixative (caption M00491). Compare blocks with documented fixation histories using the same pH 8.0 EDTA retrieval, antibody dilution, and detection run (datasheet M00491; standard IHC practice). Include a reliably staining reference section in each run, then assess nuclear signal and tissue preservation before changing retrieval or antibody concentration (HPA: selective nuclear expression; standard IHC practice). If an individual block remains weak, report its fixation history as a possible technical variable rather than attributing the result to a known PDX1 fixation effect (standard IHC practice). Do not infer fixation behavior from tissue distribution or protein modifications (UniProt P52945; HPA: tissue IHC).
What should I do when PDX1 staining looks predominantly cytoplasmic?
Prioritize distinct nuclear staining when reading paraffin sections: tissue IHC shows selective nuclear expression, and subcellular imaging supports nucleoplasmic localization (HPA: tissue IHC; HPA: subcellular). UniProt also lists cytosol, so cytoplasmic signal deserves evaluation rather than automatic dismissal (UniProt P52945: subcellular location). Compare the pattern with nuclei in pancreatic endocrine cells or duodenal enterocytes, and review a no-primary control for nonspecific color (HPA: tissue IHC; standard IHC practice). If diffuse cytoplasmic staining persists without convincing nuclei, check retrieval, antibody concentration, wash stringency, and DAB development on adjacent sections (standard IHC practice). Score nuclear and cytoplasmic compartments separately so background cannot inflate the nuclear result (standard IHC practice).
How can epitope uncertainty affect interpretation of PDX1 immunostaining?
The supplied record annotates a single 1–283 chain and no isoforms, but it does not identify M00491's binding epitope (UniProt P52945; caption M00491). PDX1 has annotated phosphorylation at residues 151 and 268; their effect on this antibody's tissue staining is unknown (UniProt P52945: modified residues). If results differ across processing conditions, compare adjacent sections and preserve the same retrieval, dilution, and detection settings during that comparison (standard IHC practice). Interpret any change as assay-dependent until independent evidence establishes the epitope or a modification-specific effect (standard IHC practice). Report the antibody identifier and retrieval condition with the staining pattern so others can assess that uncertainty (caption M00491; standard IHC practice).
How can I follow up a PDX1 IHC pattern with multiplex immunofluorescence?
Use IF as a separate assay and pair PDX1 with a marker for the expected cell population, such as insulin in pancreatic islets (UniProt P52945: beta-cell context; standard IF practice). Evaluate PDX1 in the nuclear channel and the cell marker in its appropriate compartment, using a nuclear counterstain to define cells (HPA: nucleoplasm; standard IF practice). Choose fluorophores and exposure settings after checking tissue autofluorescence in an unstained section; a longer-wavelength channel may improve separation when shorter-wavelength background is high (standard IF practice). PDX1 has no transmembrane segment and is reported in nucleus and cytosol, so validate permeabilisation that permits intracellular antibody access (UniProt P52945: topology and location; standard IF practice). Confirm that multiplex controls exclude channel bleed-through and secondary-antibody cross-reactivity before interpreting colocalisation (standard IF practice).
How do I distinguish PDX1 signal from nonspecific DAB background?
Inspect a no-primary control and the expected nuclear pattern before assigning brown signal to PDX1 (HPA: selective nuclear expression; standard IHC practice). The selected image used a peroxidase-conjugated secondary and DAB, making an endogenous peroxidase block and controlled DAB development appropriate workflow checks (caption M00491; standard IHC practice). If staining is widespread, compare stronger blocking, more stringent washing, and a primary-antibody dilution series while holding retrieval fixed at EDTA pH 8.0 (datasheet M00491; standard IHC practice). Assess folds, cut edges, and damaged areas separately because concentrated reagent or compromised tissue can mimic localized staining (standard IHC practice). Accept signal when nuclei remain distinct in expected cells and control sections stay clean (HPA: tissue IHC; standard IHC practice).
What is a reproducible way to score PDX1 in tissue sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define eligible cells and score nuclear staining, since the tissue reference pattern is selective and nuclear (HPA: tissue IHC). Record the percentage of positive nuclei and intensity categories, then calculate an H-score using a fixed scoring rubric across sections (standard IHC practice). For cell-rich regions, positive nuclei per mm² can complement the percentage, provided the analyzed area and exclusions are documented (standard IHC practice). Normalize counts to all eligible nuclei in the same annotated compartment, rather than to total section area alone, when cellularity varies (standard IHC practice). Exclude necrosis, folds, and edges consistently, and compare samples only after matching staining and imaging conditions (standard IHC practice).
When is an apparent PDX1-positive region convincing rather than artefactual?
Convincing signal is predominantly nuclear in a plausible cell population, such as pancreatic endocrine cells or duodenal enterocytes (HPA: tissue IHC). Pancreas and intestine are group-enriched for PDX1 RNA, while the selected M00491 image shows staining in a paraffin section of human stomach cancer; interpret that image in its tissue context (HPA: RNA specificity; caption M00491). Treat isolated edge staining, necrotic areas, and diffuse cytoplasmic DAB as prompts to inspect controls and section quality (standard IHC practice). Check a no-primary section and endogenous peroxidase blocking when brown deposits occur outside cells, since the illustrated detection used HRP and DAB (caption M00491; standard IHC practice). Report the proportion of convincing positive nuclei alongside morphology and control performance (standard IHC practice).
Boster reagents
Best PDX1 / Pancreas/duodenum homeobox protein 1 IHC Antibodies
Anti-PDX1 antibodies have IHC data from a human paraffin-embedded tissue section (M00491 image caption) and IF data from HeLa cells (A00491-4 image caption); both list human reactivity (catalog).
Real IHC data
Anti-PDX1/Ipf1 Rabbit Monoclonal Antibody
Cat # M00491
Real IF data
Anti-PDX1 Antibody ®
Cat # A00491-4
M00491 lists IHC and IF applications (catalog) and shows IHC staining of a paraffin-embedded human stomach cancer section (M00491 image caption). A00491-4 lists ICC/IF, but not IHC (catalog), and shows IF staining of HeLa cells (A00491-4 image caption).
Which to pick: For tissue IHC, choose the monoclonal M00491 (catalog: clone AEC-16, IHC application); its image documents a paraffin-embedded section with EDTA retrieval and 1:50 antibody dilution, but does not report the fixative (M00491 image caption). For IF/ICC, choose A00491-4, whose HeLa cell image uses 5 μg/mL (A00491-4 image caption; catalog: ICC/IF application). Neither SKU has documented cross-species reactivity beyond human (catalog: Human reactivity for both).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P52945 (PDX1_HUMAN, Pancreas/duodenum homeobox protein 1).
- Human Protein Atlas. PDX1 tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. PDX1 subcellular location (ICC-IF): Localized to the nucleoplasm..
- Human Protein Atlas. PDX1 antibody validation summary (2 antibodies).
- Pdx1 expression in pancreatic precursor lesions and neoplasms. Applied immunohistochemistry & molecular morphology : AIMM 2011 — PMC3123421.
- Mucins, trefoil factors and pancreatic duodenal homeobox 1 expression in spasmolytic polypeptide expressing metaplasia and intestinal metaplasia adjacent to gastric carcinomas. Archives of medical science : AMS 2020 — PMC7667445.
- Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele. PloS one 2017 — PMC5608307.
- 2D and 3D cultured human umbilical cord-derived mesenchymal stem cell-conditioned medium has a dual effect in type 1 diabetes model in rats: immunomodulation and beta-cell regeneration. Inflammation and regeneration 2022 — PMC9710085.
- PubMed PMID:7590740 — UniProt-cited evidence.
- PubMed PMID:8635654 — UniProt-cited evidence.
- PubMed PMID:9252422 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for PDX1 (Pancreas/duodenum homeobox protein 1). Expected localisation Nuclear staining in pancreas and intestine (HPA tissue IHC). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet M00491). Validated IHC antibody: M00491 at 1:50 (the product's own IHC validation image is shown). Controls (HPA): positive Duodenum (Enterocytes); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human stomach cancer tissue; fixative not specified (datasheet M00491); 2. Fixation: Image fixative and duration unreported (datasheet M00491); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet M00491); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet M00491); 8. Primary antibody: Rabbit monoclonal (clone AEC-16) anti-PDX1, 1:50 (datasheet M00491); 9. Primary incubation: Overnight at 4 °C (datasheet M00491). Watch for: Fixation: Keep fixation consistent across sections (standard IHC practice; not target-specific). Selected-image fixative and duration unreported (datasheet M00491); verify before use.; Caveat: Enterocytes and intercalated ducts also stain (HPA tissue IHC); Isoform / epitope: No annotated isoforms or cleavage; one 1–283 chain (UniProt); Regulation: Expression regulation unreported (UniProt). Evidence: UniProt P52945, HPA tissue IHC · Enhanced, HPA ICC-IF · nucleoplasm., Datasheet M00491, PMC3123421, PMC7667445. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/PDX1/immunohistochemistry-ihc-guide.